nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000609	0.000609	CcSEcCtD
Gadoversetamide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000607	0.000607	CcSEcCtD
Gadoversetamide—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000607	0.000607	CcSEcCtD
Gadoversetamide—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000605	0.000605	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000605	0.000605	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000603	0.000603	CcSEcCtD
Gadoversetamide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000602	0.000602	CcSEcCtD
Gadoversetamide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000602	0.000602	CcSEcCtD
Gadoversetamide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000602	0.000602	CcSEcCtD
Gadoversetamide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000602	0.000602	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000601	0.000601	CcSEcCtD
Gadoversetamide—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000601	0.000601	CcSEcCtD
Gadoversetamide—Pain—Indinavir—acquired immunodeficiency syndrome	0.000597	0.000597	CcSEcCtD
Gadoversetamide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000597	0.000597	CcSEcCtD
Gadoversetamide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000597	0.000597	CcSEcCtD
Gadoversetamide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000597	0.000597	CcSEcCtD
Gadoversetamide—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000597	0.000597	CcSEcCtD
Gadoversetamide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000596	0.000596	CcSEcCtD
Gadoversetamide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000595	0.000595	CcSEcCtD
Gadoversetamide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000594	0.000594	CcSEcCtD
Gadoversetamide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000594	0.000594	CcSEcCtD
Gadoversetamide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000593	0.000593	CcSEcCtD
Gadoversetamide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000593	0.000593	CcSEcCtD
Gadoversetamide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000593	0.000593	CcSEcCtD
Gadoversetamide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000591	0.000591	CcSEcCtD
Gadoversetamide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000591	0.000591	CcSEcCtD
Gadoversetamide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00059	0.00059	CcSEcCtD
Gadoversetamide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00059	0.00059	CcSEcCtD
Gadoversetamide—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000589	0.000589	CcSEcCtD
Gadoversetamide—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000589	0.000589	CcSEcCtD
Gadoversetamide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000589	0.000589	CcSEcCtD
Gadoversetamide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000587	0.000587	CcSEcCtD
Gadoversetamide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000586	0.000586	CcSEcCtD
Gadoversetamide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000586	0.000586	CcSEcCtD
Gadoversetamide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000586	0.000586	CcSEcCtD
Gadoversetamide—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000584	0.000584	CcSEcCtD
Gadoversetamide—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000584	0.000584	CcSEcCtD
Gadoversetamide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000583	0.000583	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000582	0.000582	CcSEcCtD
Gadoversetamide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000581	0.000581	CcSEcCtD
Gadoversetamide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000579	0.000579	CcSEcCtD
Gadoversetamide—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000578	0.000578	CcSEcCtD
Gadoversetamide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000576	0.000576	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000575	0.000575	CcSEcCtD
Gadoversetamide—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000575	0.000575	CcSEcCtD
Gadoversetamide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000574	0.000574	CcSEcCtD
Gadoversetamide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000574	0.000574	CcSEcCtD
Gadoversetamide—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000573	0.000573	CcSEcCtD
Gadoversetamide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000573	0.000573	CcSEcCtD
Gadoversetamide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000573	0.000573	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000572	0.000572	CcSEcCtD
Gadoversetamide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000572	0.000572	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000571	0.000571	CcSEcCtD
Gadoversetamide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000571	0.000571	CcSEcCtD
Gadoversetamide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00057	0.00057	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00057	0.00057	CcSEcCtD
Gadoversetamide—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000569	0.000569	CcSEcCtD
Gadoversetamide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000569	0.000569	CcSEcCtD
Gadoversetamide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000569	0.000569	CcSEcCtD
Gadoversetamide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000567	0.000567	CcSEcCtD
Gadoversetamide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000567	0.000567	CcSEcCtD
Gadoversetamide—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000567	0.000567	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000565	0.000565	CcSEcCtD
Gadoversetamide—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000564	0.000564	CcSEcCtD
Gadoversetamide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000564	0.000564	CcSEcCtD
Gadoversetamide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000564	0.000564	CcSEcCtD
Gadoversetamide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000564	0.000564	CcSEcCtD
Gadoversetamide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000563	0.000563	CcSEcCtD
Gadoversetamide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000563	0.000563	CcSEcCtD
Gadoversetamide—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000562	0.000562	CcSEcCtD
Gadoversetamide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000561	0.000561	CcSEcCtD
Gadoversetamide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000561	0.000561	CcSEcCtD
Gadoversetamide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000559	0.000559	CcSEcCtD
Gadoversetamide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000559	0.000559	CcSEcCtD
Gadoversetamide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000559	0.000559	CcSEcCtD
Gadoversetamide—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000557	0.000557	CcSEcCtD
Gadoversetamide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000557	0.000557	CcSEcCtD
Gadoversetamide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000556	0.000556	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000556	0.000556	CcSEcCtD
Gadoversetamide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000555	0.000555	CcSEcCtD
Gadoversetamide—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000553	0.000553	CcSEcCtD
Gadoversetamide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000553	0.000553	CcSEcCtD
Gadoversetamide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000552	0.000552	CcSEcCtD
Gadoversetamide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000552	0.000552	CcSEcCtD
Gadoversetamide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000551	0.000551	CcSEcCtD
Gadoversetamide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000551	0.000551	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00055	0.00055	CcSEcCtD
Gadoversetamide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00055	0.00055	CcSEcCtD
Gadoversetamide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000549	0.000549	CcSEcCtD
Gadoversetamide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000547	0.000547	CcSEcCtD
Gadoversetamide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000547	0.000547	CcSEcCtD
Gadoversetamide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000546	0.000546	CcSEcCtD
Gadoversetamide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000546	0.000546	CcSEcCtD
Gadoversetamide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000546	0.000546	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000545	0.000545	CcSEcCtD
Gadoversetamide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000545	0.000545	CcSEcCtD
Gadoversetamide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000545	0.000545	CcSEcCtD
Gadoversetamide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000544	0.000544	CcSEcCtD
Gadoversetamide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000544	0.000544	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000543	0.000543	CcSEcCtD
Gadoversetamide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000543	0.000543	CcSEcCtD
Gadoversetamide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000541	0.000541	CcSEcCtD
Gadoversetamide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000541	0.000541	CcSEcCtD
Gadoversetamide—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000541	0.000541	CcSEcCtD
Gadoversetamide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00054	0.00054	CcSEcCtD
Gadoversetamide—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00054	0.00054	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00054	0.00054	CcSEcCtD
Gadoversetamide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000539	0.000539	CcSEcCtD
Gadoversetamide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000537	0.000537	CcSEcCtD
Gadoversetamide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000536	0.000536	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000536	0.000536	CcSEcCtD
Gadoversetamide—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000536	0.000536	CcSEcCtD
Gadoversetamide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000536	0.000536	CcSEcCtD
Gadoversetamide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000533	0.000533	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000532	0.000532	CcSEcCtD
Gadoversetamide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000532	0.000532	CcSEcCtD
Gadoversetamide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000532	0.000532	CcSEcCtD
Gadoversetamide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000528	0.000528	CcSEcCtD
Gadoversetamide—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000528	0.000528	CcSEcCtD
Gadoversetamide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000526	0.000526	CcSEcCtD
Gadoversetamide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000525	0.000525	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000525	0.000525	CcSEcCtD
Gadoversetamide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000524	0.000524	CcSEcCtD
Gadoversetamide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000524	0.000524	CcSEcCtD
Gadoversetamide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000522	0.000522	CcSEcCtD
Gadoversetamide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000522	0.000522	CcSEcCtD
Gadoversetamide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000521	0.000521	CcSEcCtD
Gadoversetamide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000521	0.000521	CcSEcCtD
Gadoversetamide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00052	0.00052	CcSEcCtD
Gadoversetamide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000519	0.000519	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000518	0.000518	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000516	0.000516	CcSEcCtD
Gadoversetamide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000515	0.000515	CcSEcCtD
Gadoversetamide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000515	0.000515	CcSEcCtD
Gadoversetamide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000514	0.000514	CcSEcCtD
Gadoversetamide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000514	0.000514	CcSEcCtD
Gadoversetamide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000513	0.000513	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000512	0.000512	CcSEcCtD
Gadoversetamide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000511	0.000511	CcSEcCtD
Gadoversetamide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000508	0.000508	CcSEcCtD
Gadoversetamide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000508	0.000508	CcSEcCtD
Gadoversetamide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000506	0.000506	CcSEcCtD
Gadoversetamide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000505	0.000505	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000504	0.000504	CcSEcCtD
Gadoversetamide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000504	0.000504	CcSEcCtD
Gadoversetamide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000502	0.000502	CcSEcCtD
Gadoversetamide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000501	0.000501	CcSEcCtD
Gadoversetamide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000501	0.000501	CcSEcCtD
Gadoversetamide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000501	0.000501	CcSEcCtD
Gadoversetamide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.0005	0.0005	CcSEcCtD
Gadoversetamide—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000499	0.000499	CcSEcCtD
Gadoversetamide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000499	0.000499	CcSEcCtD
Gadoversetamide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000499	0.000499	CcSEcCtD
Gadoversetamide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000499	0.000499	CcSEcCtD
Gadoversetamide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000497	0.000497	CcSEcCtD
Gadoversetamide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000495	0.000495	CcSEcCtD
Gadoversetamide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000494	0.000494	CcSEcCtD
Gadoversetamide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000489	0.000489	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000489	0.000489	CcSEcCtD
Gadoversetamide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000486	0.000486	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000485	0.000485	CcSEcCtD
Gadoversetamide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000485	0.000485	CcSEcCtD
Gadoversetamide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000485	0.000485	CcSEcCtD
Gadoversetamide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000482	0.000482	CcSEcCtD
Gadoversetamide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000481	0.000481	CcSEcCtD
Gadoversetamide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000481	0.000481	CcSEcCtD
Gadoversetamide—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000481	0.000481	CcSEcCtD
Gadoversetamide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000478	0.000478	CcSEcCtD
Gadoversetamide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000478	0.000478	CcSEcCtD
Gadoversetamide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000478	0.000478	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000478	0.000478	CcSEcCtD
Gadoversetamide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000477	0.000477	CcSEcCtD
Gadoversetamide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000474	0.000474	CcSEcCtD
Gadoversetamide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000474	0.000474	CcSEcCtD
Gadoversetamide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000473	0.000473	CcSEcCtD
Gadoversetamide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000472	0.000472	CcSEcCtD
Gadoversetamide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000471	0.000471	CcSEcCtD
Gadoversetamide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000467	0.000467	CcSEcCtD
Gadoversetamide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000466	0.000466	CcSEcCtD
Gadoversetamide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000465	0.000465	CcSEcCtD
Gadoversetamide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000464	0.000464	CcSEcCtD
Gadoversetamide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000463	0.000463	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000463	0.000463	CcSEcCtD
Gadoversetamide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000462	0.000462	CcSEcCtD
Gadoversetamide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000462	0.000462	CcSEcCtD
Gadoversetamide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000462	0.000462	CcSEcCtD
Gadoversetamide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000462	0.000462	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00046	0.00046	CcSEcCtD
Gadoversetamide—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000459	0.000459	CcSEcCtD
Gadoversetamide—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000459	0.000459	CcSEcCtD
Gadoversetamide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000453	0.000453	CcSEcCtD
Gadoversetamide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000452	0.000452	CcSEcCtD
Gadoversetamide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000447	0.000447	CcSEcCtD
Gadoversetamide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000447	0.000447	CcSEcCtD
Gadoversetamide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000446	0.000446	CcSEcCtD
Gadoversetamide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000444	0.000444	CcSEcCtD
Gadoversetamide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000444	0.000444	CcSEcCtD
Gadoversetamide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000444	0.000444	CcSEcCtD
Gadoversetamide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000442	0.000442	CcSEcCtD
Gadoversetamide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000441	0.000441	CcSEcCtD
Gadoversetamide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00044	0.00044	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000439	0.000439	CcSEcCtD
Gadoversetamide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000438	0.000438	CcSEcCtD
Gadoversetamide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000437	0.000437	CcSEcCtD
Gadoversetamide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000432	0.000432	CcSEcCtD
Gadoversetamide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00043	0.00043	CcSEcCtD
Gadoversetamide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000426	0.000426	CcSEcCtD
Gadoversetamide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000424	0.000424	CcSEcCtD
Gadoversetamide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000424	0.000424	CcSEcCtD
Gadoversetamide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00042	0.00042	CcSEcCtD
Gadoversetamide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000419	0.000419	CcSEcCtD
Gadoversetamide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000418	0.000418	CcSEcCtD
Gadoversetamide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000416	0.000416	CcSEcCtD
Gadoversetamide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000416	0.000416	CcSEcCtD
Gadoversetamide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000415	0.000415	CcSEcCtD
Gadoversetamide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000414	0.000414	CcSEcCtD
Gadoversetamide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000414	0.000414	CcSEcCtD
Gadoversetamide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000413	0.000413	CcSEcCtD
Gadoversetamide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000403	0.000403	CcSEcCtD
Gadoversetamide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000402	0.000402	CcSEcCtD
Gadoversetamide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.0004	0.0004	CcSEcCtD
Gadoversetamide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000398	0.000398	CcSEcCtD
Gadoversetamide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000398	0.000398	CcSEcCtD
Gadoversetamide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000398	0.000398	CcSEcCtD
Gadoversetamide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000396	0.000396	CcSEcCtD
Gadoversetamide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000395	0.000395	CcSEcCtD
Gadoversetamide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000392	0.000392	CcSEcCtD
Gadoversetamide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000386	0.000386	CcSEcCtD
Gadoversetamide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000385	0.000385	CcSEcCtD
Gadoversetamide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000385	0.000385	CcSEcCtD
Gadoversetamide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000379	0.000379	CcSEcCtD
Gadoversetamide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000375	0.000375	CcSEcCtD
Gadoversetamide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000372	0.000372	CcSEcCtD
Gadoversetamide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000371	0.000371	CcSEcCtD
Gadoversetamide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000368	0.000368	CcSEcCtD
Gadoversetamide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000368	0.000368	CcSEcCtD
Gadoversetamide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000367	0.000367	CcSEcCtD
Gadoversetamide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000366	0.000366	CcSEcCtD
Gadoversetamide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000357	0.000357	CcSEcCtD
Gadoversetamide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000355	0.000355	CcSEcCtD
Gadoversetamide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000354	0.000354	CcSEcCtD
Gadoversetamide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000354	0.000354	CcSEcCtD
Gadoversetamide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000352	0.000352	CcSEcCtD
Gadoversetamide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000347	0.000347	CcSEcCtD
Gadoversetamide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000341	0.000341	CcSEcCtD
Gadoversetamide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000338	0.000338	CcSEcCtD
Gadoversetamide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000338	0.000338	CcSEcCtD
Gadoversetamide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000336	0.000336	CcSEcCtD
Gadoversetamide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000334	0.000334	CcSEcCtD
Gadoversetamide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000319	0.000319	CcSEcCtD
